Navigation Links
DelMar Pharmaceuticals, Inc. Provides Corporate Update for the Quarter Ended March 31, 2013
Date:5/16/2013

VANCOUVER, British Columbia and MENLO PARK, Calif., May 16, 2013 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar Pharma") is pleased to provide the following update from President & CEO, Mr. Jeffrey Bacha :

During the past quarter, we continued to advance our lead product candidate VAL-083 in an ongoing brain cancer clinical trial.  Our current trial is a dose-escalating study designed to evaluate the safety and efficacy of VAL-083 as a potential treatment for glioblastoma multiforme (GBM) and metastatic brain cancer for patients who have failed or are otherwise ineligible for currently approved treatments. 

We recently presented encouraging data at the American Association of Cancer Research (AACR) 2013 annual meeting showing that VAL-083, at doses tested to date:

  • Is safe and well tolerated in patients who have failed other available therapies;
  • Demonstrated a dose response, as expected, based on observations reported in the historical literature; and
  • Demonstrated clinical activity: an overall response rate of 33.3% was observed, where tumor growth had stabilized or regressed, in patients that had failed other therapies.

Based on these observations, we are focused on completing the dose escalation portion of the clinical trial with the goal of positioning VAL-083 for advancement into registration directed clinical trials.  We anticipate presenting additional data at upcoming scientific meetings during 2013.

In addition to our clinical development activities in the United States, we have obtained exclusive commercial rights to VAL-083 in China, where the drug is approved as a chemotherapy for the treatment or chronic myelogenous leukemia (CML) and lung cancer.  Our strateg
'/>"/>

SOURCE DelMar Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. DelMar Pharmaceuticals to Present Interim Clinical Data on VAL-083 in Refractory Glioblastoma at Society for Neuro-Oncology (SNO) Annual Meeting
2. DelMar Pharmaceuticals Announces $1.0 Million Third Closing in Private Placement
3. DelMar Pharmaceuticals Announces $1.6 Million Closing in Private Placement
4. DelMar Pharmaceuticals Announces Appointment of John K. Bell to Board of Directors
5. DelMar Pharmaceuticals Announces Completion Of $10.5 Million Oversubscribed Offering And Appointment Of Investor Relations Consultant
6. DelMar Pharmaceuticals to Present at the 25th Annual ROTH Capital Partners Growth Stock Conference
7. DelMar Pharma Named to Rocket Builders 2013"Ready to Rocket" List
8. DelMar Pharmaceuticals to Present Clinical Data from VAL-083 Brain Cancer Trial at the American Association of Cancer Research Annual Meeting
9. DelMar Pharma Presents Encouraging Data From Ongoing Phase I/II GBM Clinical Trial With VAL-083
10. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
11. Provectus Pharmaceuticals, Inc.s Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... 11, 2014 Research and Markets ... Chinese Medical X-ray Film Industry Report 2014" report ... Global And Chinese Medical X-Ray Film ... on the current state of the Global medical X-ray ... The report provides a basic overview of the ...
(Date:7/11/2014)...  Kindred Hospital Houston Northwest, with Wound Care ... its new outpatient wound healing center.  The wound ... chronic, hard to heal wounds. Chronic wounds include ... lower leg wounds related to blood flow issues, ... injury wounds which are complex and demonstrate delayed ...
(Date:7/11/2014)... , July 11, 2014 According ... Research "Endoscopy Devices Market (Endoscopes, Endoscopic Operative Devices, and ... Trends and Forecast, 2013-2019" the global endoscopy devices market ... is expected to grow at a CAGR of 6.8% ... of USD 36.9 billion in 2019. Browse ...
Breaking Medicine Technology:Global and Chinese Medical X-ray Film Industry Report 2014 2Kindred Hospital Houston Northwest, With Wound Care Specialists, Opens Outpatient Wound Healing And Hyperbaric Center 2Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 2Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 5Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 6
(Date:7/13/2014)... WA (PRWEB) July 13, 2014 According to ... this is a step by step guide on what to ... easily and quickly. Vkool writes in its review that ... foods to eat to revitalize their kidney health. Vkool also ... can help people reverse their damaged kidney functions naturally. The ...
(Date:7/13/2014)... A Xarelto lawsuit webpage has been launched ... with the most current information regarding serious internal bleeding ... as well as the growing number of Xarelto ... The law firm is now offering free legal evaluations ... bleeding and related complications while using Xarelto, including:, ...
(Date:7/13/2014)... ECS is being founded by ... of a special needs child, I have become keenly ... for contemporary special education resources and evidence-based instruction. Emerald ... and families in the Seattle metro area that are ... education. We welcome the opportunity to serve our community ...
(Date:7/13/2014)... Ann Arbor, MI (PRWEB) July 13, 2014 ... online learning program he has just launched at http://www.HealthYourself101.com ... management of visceral obesity. , Power has set out ... and its ill effects that’s actually – dare we say ... , “The program,” says Power, “aims to engage the remote ...
(Date:7/13/2014)... Wa (PRWEB) July 13, 2014 According ... by Vkool.com, this is a comprehensive guide that features ... deal with KP (keratosis pilaris). This guide ... 1: What Is Keratosis Pilaris? ,     Chapter 2: ... I Know If I Have KP? ,     Chapter ...
Breaking Medicine News(10 mins):Health News:Kidney Disease Solution Book Review Exposes Duncan Capicchiano's Newly Updated Kidney Disease Treatment Plan – Vkool.com 2Health News:Kidney Disease Solution Book Review Exposes Duncan Capicchiano's Newly Updated Kidney Disease Treatment Plan – Vkool.com 3Health News:Xeralto Lawsuit Page Launched By Wright & Schulte LLC To Provide Information On Potential For Xarelto Bleeding Side Effects, Growing Litigation 2Health News:Xeralto Lawsuit Page Launched By Wright & Schulte LLC To Provide Information On Potential For Xarelto Bleeding Side Effects, Growing Litigation 3Health News:Xeralto Lawsuit Page Launched By Wright & Schulte LLC To Provide Information On Potential For Xarelto Bleeding Side Effects, Growing Litigation 4Health News:New Private School, Emerald City School, Founded in Downtown Seattle Now Accepting 1st to 6th Grade Students Who Learn Differently 2Health News:Retired Ann Arbor Physician and Professor Wields New Media to Teach Health Science 2Health News:Retired Ann Arbor Physician and Professor Wields New Media to Teach Health Science 3Health News:Retired Ann Arbor Physician and Professor Wields New Media to Teach Health Science 4Health News:Living With KP Book Review Exposes Jennifer Richards' Keratosis Pilaris Guide – Vkool.com 2Health News:Living With KP Book Review Exposes Jennifer Richards' Keratosis Pilaris Guide – Vkool.com 3
... (Nasdaq: MLAB ) today reported record sales and net income ... -- Annual revenue increases 13% to a new record -- ... Annual net income increases 16% to a new record -- ... Fourth quarter operating income increases 7% to a new record, ...
... Expertise for Partners ... the Google Health Platform, PORTLAND, Ore., May 19 ... company, announced,collaboration today with Google as a development and consulting ... public at an,event at Google,s headquarters today; the product allows ...
... can now not only feel the spicy kick of a ... thanks to researchers at Baylor College of Medicine in Houston. ... Theodore G. Wensel, professor of biochemistry and molecular biology at ... that allows you to sense the heat of a hot ...
... Only half of patients had their therapy changed as ... -- Diabetics with high blood pressure have only a ... as needed or offer other treatment, a new study ... diabetes is very important, because elevated pressure can lead ...
... the antidepressant citalopram before beginning treatment for head and ... to results of a pilot study published in the ... one of the JAMA/Archives journals. , Treatment for head ... authors write as background information in the article. Psychiatric ...
... Case Medical Center (UHCMC) finds that elderly patients ... are not treated as aggressively as patients between 65 ... that if patients over 75 years old are treated ... better survival rates. The findings appear in the April ...
Cached Medicine News:Health News:Mesa Labs Reports Record Year End Sales and Earnings 2Health News:Mesa Labs Reports Record Year End Sales and Earnings 3Health News:Mesa Labs Reports Record Year End Sales and Earnings 4Health News:Mesa Labs Reports Record Year End Sales and Earnings 5Health News:Mesa Labs Reports Record Year End Sales and Earnings 6Health News:Mount Tabor Collaborates with Google Health 2Health News:Some like it hot! Structure of receptor for hot chili pepper and pain revealed 2Health News:Many Diabetics Don't Get Necessary Blood Pressure Treatment 2Health News:Many Diabetics Don't Get Necessary Blood Pressure Treatment 3Health News:Medication may prevent depression in patients with head and neck cancer 2Health News:Study: Patients 75 years and older with brain tumors may benefit from more aggressive treatment 2
... The Genesis II* Total Knee System ... Now, far more is possible with less ... options, while fully addressing both clinical and ... components meet these design goals, giving surgeons ...
Cruciate retaining, posterior stabilized and constrained components....
... The TC-PLUS Solution tricompartmental total knee prosthesis ... knee arthroplasty. State-of-the-art design and manufacturing technologies ... optimum biomechanical function as well as a ... tibial insert to keep wear to a ...
...
Medicine Products: